Online Inquiry

tRNA Integrity Assessment

The functional reliability of transfer RNA (tRNA) depends on its structural integrity, chemical completeness, and modification status. Even minor degradation, misfolding, or hypomodification can disrupt aminoacylation, codon decoding, and non-canonical amino acid (ncAA) incorporation efficiency.

Through the GCEngine platform, we provide a comprehensive tRNA integrity assessment service designed to evaluate the purity, folding, stability, and modification fidelity of tRNA molecules—whether synthetic, engineered, or purified from cells. Our multi-level analytical framework ensures that every tRNA entering your translational system performs as intended, maintaining decoding accuracy and translational efficiency.

Introduction to tRNA Integrity Assessment

tRNAs are compact yet highly complex RNAs, typically 70–80 nucleotides long, folding into a conserved cloverleaf secondary and L-shaped tertiary structure stabilized by numerous base modifications and intramolecular interactions. Their integrity is a composite property encompassing:

  • Structural integrity —mapped secondary structure and evidence supporting higher-order folding; absence of truncations.
  • Chemical integrity — expected post-transcriptional modifications and 3'-CCA status.
  • Functional integrity — aminoacylation and ternary-complex formation in defined assays.

Loss of tRNA integrity—through incomplete transcription, RNase degradation, hypomodification, or chemical oxidation—can cause ribosome stalling and translational errors. Systematic assessment is therefore essential before using tRNAs in engineered translation, radiolabeling, or therapeutic screening systems.

Modifications of the tRNAFig.1 3'-tail integrity and CCA maturation can be inferred from 3'-end features (Czech A., 2020)

Our Services

Our integrity workflow combines electrophoresis, UV–melting, in-silico folding, and analytical chemistry to produce a traceable integrity profile for each tRNA batch.

Note: Results are reported with fit-for-purpose thresholds; they are assay-agnostic and do not assume a specific genetic-code-expansion setup.

Structural Integrity Evaluation

We determine truncation status and map secondary-structure features with evidence supporting higher-order folding.

  • Native and denaturing PAGE to assess size uniformity and structural homogeneity.
  • Circular dichroism (CD) and UV-melting analysis to determine thermal stability and folding cooperativity.
  • Selective chemical probing (SHAPE / DMS / RNase footprinting) to map flexible versus structured regions.
  • In-silico folding/energetics

Identify structural disruptions caused by mutation, truncation, or chemical modification; confirm correct folding architecture.

Chemical and Modification Integrity

We analyze whether each expected nucleotide modification is present and chemically intact, since incomplete or erroneous modifications directly affect tRNA decoding fidelity.

  • LC–MS/MS to profile all modified nucleosides (Ψ, m¹A, m⁵C, m⁷G, Q, s²U, etc.).
  • Demethylase-assisted reads (e.g., ARM-seq/DM-TGIRT-seq) to support site attribution.

Verify modification completeness and ensure proper maturation for translation efficiency and aaRS recognition.

3'-End Maturation and Aminoacylation Readiness

We verify 3'-CCA status and, when applicable, charging/ternary-complex competency.

  • CCA-end ligation or targeted RT-assays for 3'-tail status.
  • Aminoacylation assay using cognate or orthogonal aaRSs to measure charging rate (kcat/Km).
  • EF-Tu or eEF1A binding tests to evaluate ternary-complex formation efficiency.

Demonstrate that the tRNA is chemically matured and retain accessibility in translational initiation and elongation.

Functional Integrity and Decoding Activity

Depending on scope, we test whether the tRNA performs as expected in translation, ensuring that structure and modification integrity translate into actual decoding precision.

  • In vitro translation or dual-reporter assays to quantify decoding efficiency and misincorporation frequency.
  • Ribosome binding and translocation analysis (fluorescence- or isotope-labeled tracking).

Confirm that intact tRNAs drive accurate, efficient translation and ncAA incorporation.

Contact Us

Sound experimental results start with well-characterized tRNA materials. Our integrity assessment provides traceable, assay-agnostic documentation and optional functional checks. Contact us today to schedule a tRNA integrity assessment or to integrate our testing module into your modification or ncAA development workflow.

Reference

  1. Czech A. (2020). Deep sequencing of tRNA's 3'-termini sheds light on CCA-tail integrity and maturation. RNA (New York, N.Y.), 26(2), 199–208.
Rare Skin Diseases

A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.

Contact Us